Literature DB >> 717957

Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program.

W A Craig, S J Uman, W R Shaw, V Ramgopal, L L Eagan, E T Leopold.   

Abstract

Costs and use of antimicrobial agents in 1976 at 19 hospitals were surveyed by review of pharmacy records. Total costs of antimicrobial drugs at individual hospitals ranged from $0.65 to $1.75 per patient day and accounted for 16% to 41% of total pharmacy drug costs. There was marked variation among hospitals in use of specific antimicrobial agents, especially cephalosporins and clindamycin. The cephalosporin and aminoglycoside antibiotics accounted for 66% of the total cost of antimicrobial agents. An 18-month antimicrobial drug control program at one hospital decreased antimicrobial drug costs by 31%. The major effect was in reducing cephalosporin use. The results of the control program document that a significant portion of hospital antimicrobial use is inappropriate and can be eliminated without apparent detriment to patient care.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717957     DOI: 10.7326/0003-4819-89-5-793

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Use of perioperative antibiotic prophylaxis in selected surgical procedures--results of a survey in 889 surgical departments in German hospitals.

Authors:  I Kappstein; F D Daschner
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

3.  Antibiotic usage in community-acquired pneumonia: results of a survey in 288 departments of internal medicine in German hospitals.

Authors:  I Kappstein; F D Daschner
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

Review 4.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Antibiotic cost reduction by providing cost information.

Authors:  E Rubinstein; A Barzilai; S Segev; Y Samra; M Modan; O Dickerman; C Haklai
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Quality of use of parenteral metronidazole therapy in a teaching hospital.

Authors:  P J Jewesson; R L Bachand; G A Bell; R J Ensom; A W Chow
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

Review 7.  The role of the infectious diseases physician in monitoring antimicrobial use: a pharmacy perspective.

Authors:  R E Polk
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

8.  Containing cefoxitin costs through a program to curtail use in surgical prophylaxis.

Authors:  G Taylor; E Blondel-Hill; P Kibsey; E Friesen; R Tisdell; W Vaudry
Journal:  Can J Infect Dis       Date:  1993-09

9.  Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial.

Authors:  K G Shojania; D Yokoe; R Platt; J Fiskio; N Ma'luf; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 Nov-Dec       Impact factor: 4.497

10.  Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada.

Authors:  James M Hutchinson; David M Patrick; Fawziah Marra; Helen Ng; William R Bowie; Laurie Heule; Mark Muscat; Dominique L Monnet
Journal:  Can J Infect Dis       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.